Cita APA

Melero, I. (., Velasco, G. (. d., Moreno, V. (., Oberoi, H. (., Shepherd, C. (., Jones, D. (., . . . Garralda, E. (. (2021). A first-in-human phase I study of FS222, a CD137/PD-L1 tetravalent bispecific antibody, in patients with advanced malignancies.

Citación estilo Chicago

Melero, I. (Ignacio)|||/items/82113ea8-7ce1-49d5-9ee3-42cf20db1c4e, et al. A First-in-human Phase I Study of FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, in Patients With Advanced Malignancies. 2021.

Cita MLA

Melero, I. (Ignacio)|||/items/82113ea8-7ce1-49d5-9ee3-42cf20db1c4e, et al. A First-in-human Phase I Study of FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, in Patients With Advanced Malignancies. 2021.